Skip to content
OpenCapital
Get started

Amneal Pharmaceuticals, Inc. AMRX Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Insmed logo
InsmedINSM
$32.68M+16.4%
Teradyne, Inc. logo
Teradyne, Inc.TER
$135.56M+14.7%
ON Semiconductor logo
ON SemiconductorON
$144.3M-12.1%

Segments

By segment

See full
Affordable Medicines$6.3M-7.6%

Other financials

Income statement

See full
Revenue$722.5M+3.9%
Gross profit$320.1M+25.1%
Operating income$141.8M+41.3%
Net income$62.3M+411%
EPS (diluted)$0.19+375%

Balance sheet

See full
Cash & equivalents$197.7M+234%
Total debt$2.6B+17.7%
Total equity-$45.4M+65.5%
Total assets$3.5B+5.2%

Cash flow

See full
Operating cash flow-$26.7M-461%
CapEx$8.2M-37.9%
Free cash flow-$34.9M-507%

Valuation

See full
Market cap$5.17B+51.0%

Profitability

See full
Gross margin38.7%+2.0pp
Operating margin14.3%+1.6pp
Net margin4%+3.6pp
FCF margin7.9%-1.0pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity127.9×+119×
Current ratio2.5×+1.1×